A topical cream that helps regulate macrophage activity was effective in treating diabetic foot ulcers, a clinical trial reported. In 236 patients with foot ulcers treated for 16 weeks, the proportion ...

Can you help us improve treatment of diabetic foot ulcers? Diabetic foot ulcers usually are located on weight-bearing plantar surfaces, the medial surface of the metatarsophalangeal joint, the lateral ...

Living with diabetes means constantly keeping an eye on things that most people never have to think twice about. Blood sugar levels, skin changes, foot checks, and meal planning become a way of life.

Mr. J’s medical history included type 2 DM, DFU with osteomyelitis, obesity, hypothyroidism, and hyperlipidemia. Medications included insulin (Humulin 70/30) b.i.d., levothyroxine, pravastatin, ...

For more than two decades, Saint Peter’s University Hospital has been a leader in the comprehensive, evidence-based advanced treatment of chronic, non-healing wounds. Wound Care Center® and Hyperbaric ...

An estimated 29.1 million people (9.3 percent of the population) have diabetes, and nearly 28 percent are not diagnosed. Age, diet, activity level, obesity and heredity are all risk facts for diabetes ...

Patients suffering from chronic diabetic foot ulcers (DFUs) could experience at least a fourfold increase in healing over standard of care with 12 weeks of home-based topical wound oxygen (TWO2) ...

This study is a randomized, prospected, controlled, clinical trial. A total of 30 patients were recruited from the Diabetic Ambulatory of Endocrinology Unit of the University of Bari (Italy) between ...

Please provide your email address to receive an email when new articles are posted on . In a longitudinal, prospective study, Kalan and colleagues analyzed data from 46 patients with neuropathic ...

A comprehensive foot examination is essential for the appropriate assessment, prevention and management of diabetic foot complications Peripheral neuropathy is concurrent with 90% of foot ulcers and ...

The first patient has been dosed in a Phase III trial assessing ViroMed’s VM202, the first pivotal study of a gene therapy indicated for patients with nonhealing diabetic foot ulcers (NHU) and ...

Ottawa, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The North America diabetic foot ulcer treatment market size was valued at USD 1.27 billion in 2024 and is predicted to reach around USD 2.22 billion by 2034, ...